GridAI Technologies GRDX
NASDAQ GRDX
$3.57 -0.18 (-4.83%)
As of: Aug 21, 2026 · 3:59 PM EDT

GridAI Technologies (GRDX) Net Equity Issued and Repurchased (2017 - 2023)

GridAI Technologies' (GRDX) quarterly Net Equity Issued and Repurchased came in at $2.3 million in Q4 2023, up 8094.39% YoY from $28068.0 in Q4 2022, and up 27.78% on a QoQ basis from $1.8 million in Q3 2023.

GridAI Technologies (GRDX) Net Equity Issued and Repurchased (2017 - 2023) Analysis & Trends

GridAI Technologies (GRDX) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $2.3 million in Q4 2023.

  • Quarterly Net Equity Issued and Repurchased rose 8094.39% year-over-year to $2.3 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $10.1 million (down 36.94% YoY) and the FY2025 annual result came in at $2.1 million, up 23.53% from the prior year.
  • Net Equity Issued and Repurchased improved to $2.3 million in Q4 2023, from $1.8 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $9.1 million in Q1 2021 to a low of -$15267.0 in Q4 2019.
  • A 5-year average of $3.3 million and a median of $2.2 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2019 — Net Equity Issued and Repurchased surged 3632469.11% — and 2022, when it plunged 97.31%.
  • Tracing GRDX's Net Equity Issued and Repurchased over 5 years: stood at -$15267.0 in 2019, then soared by 5630.54% to $844348.0 in 2020, then gained by 23.64% to $1.0 million in 2021, then sank by 97.31% to $28068.0 in 2022, then surged by 8094.39% to $2.3 million in 2023.
  • The last three Net Equity Issued and Repurchased figures came in at $2.3 million (Q4 2023), $1.8 million (Q3 2023), and $2.2 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 GridAI Technologies 5.82 Mn 5.82 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 2.30 Mn
Dec 31, 2023 2.30 Mn
Sep 30, 2023 1.80 Mn
Sep 30, 2023 1.80 Mn
Jun 30, 2023 2.20 Mn
Jun 30, 2023 2.20 Mn
Mar 31, 2023 3.80 Mn
Mar 31, 2023 3.80 Mn
Dec 31, 2022 28,068.00
Dec 31, 2022 28,068.00
Sep 30, 2022 7.70 Mn
Sep 30, 2022 7.70 Mn
Jun 30, 2022 289,322.00
Jun 30, 2022 289,322.00
Mar 31, 2022 8.00 Mn
Mar 31, 2022 8.00 Mn
Dec 31, 2021 1.04 Mn
Dec 31, 2021 1.04 Mn
Sep 30, 2021 7.40 Mn
Sep 30, 2021 7.40 Mn